Complaints Evaluation and Handling MCQs With Answer — Introduction
This blog presents a focused set of multiple-choice questions on Complaints Evaluation and Handling tailored for M.Pharm students studying Quality Management Systems (MQA 102T). The MCQs probe practical elements of complaint intake, triage, investigation, root-cause analysis, CAPA, sample retention, recall decision-making, trend analysis and regulatory expectations. Each question is designed to test conceptual understanding and application of GMP-based quality procedures used in pharmaceutical operations. Attempt these MCQs under timed conditions to simulate exam settings and identify knowledge gaps; detailed practice will strengthen your ability to ensure product quality, patient safety and regulatory compliance in real-world roles.
Q1. What is the most appropriate definition of a product complaint in pharmaceutical quality management?
- Any marketing feedback that can improve product promotion
- Any written, electronic or oral communication that alleges deficiencies related to the identity, quality, purity or potency of a drug product
- A routine customer satisfaction survey response
- An internal audit finding about documentation
Correct Answer: Any written, electronic or oral communication that alleges deficiencies related to the identity, quality, purity or potency of a drug product
Q2. How does a product complaint differ from an adverse drug reaction (ADR)?
- A complaint always indicates a manufacturing deviation while an ADR is always recreational
- An ADR relates to an untoward medical occurrence in a patient; a complaint primarily alleges a product quality or manufacturing issue
- There is no difference; both terms are interchangeable
- Complaints are only about packaging and ADRs only about storage
Correct Answer: An ADR relates to an untoward medical occurrence in a patient; a complaint primarily alleges a product quality or manufacturing issue
Q3. What is the appropriate immediate action upon receipt of a product complaint indicating potential health risk?
- Ignore until periodic review meeting
- Record the complaint in the complaint log, triage for health risk and quarantine associated batch or returned material
- Destroy the returned product immediately
- Issue a press release before investigation
Correct Answer: Record the complaint in the complaint log, triage for health risk and quarantine associated batch or returned material
Q4. What is the recommended practice for retention of complaint samples?
- Never retain samples; return them to the customer
- Retain a representative sample from the implicated batch, in appropriate storage, until the investigation is complete
- Retain only packaging components, not the product
- Retain samples only after regulatory request
Correct Answer: Retain a representative sample from the implicated batch, in appropriate storage, until the investigation is complete
Q5. Which root-cause analysis tool is commonly used to systematically identify potential sources of a complaint?
- Monte Carlo simulation
- Ishikawa (fishbone) analysis
- Random sampling without hypothesis
- Only subjective opinion without documentation
Correct Answer: Ishikawa (fishbone) analysis
Q6. Which sequence best represents the CAPA process in complaint handling?
- Preventive action → Investigation → Corrective action → Effectiveness check
- Investigation → Corrective action → Preventive action → Effectiveness check
- Corrective action → Investigation → Preventive action → Review
- Effectiveness check → Corrective action → Investigation → Closure
Correct Answer: Investigation → Corrective action → Preventive action → Effectiveness check
Q7. If investigation identifies a supplier-related cause for a complaint, the most appropriate next step is:
- Ignore supplier responsibility and fix in-house only
- Initiate supplier notification, request supplier root cause and CAPA, and evaluate supplier performance and incoming controls
- Terminate the supplier immediately without investigation
- Proceed with product recall before contacting supplier
Correct Answer: Initiate supplier notification, request supplier root cause and CAPA, and evaluate supplier performance and incoming controls
Q8. For proactive quality oversight, what is an appropriate frequency to perform complaint trend analysis?
- Quarterly, with additional immediate review for safety-significant trends
- Only once per product lifecycle
- Every ten years
- Trend analysis is unnecessary for pharmaceutical products
Correct Answer: Quarterly, with additional immediate review for safety-significant trends
Q9. Which of the following classification schemes is commonly used to assess complaint severity in GMP systems?
- Critical, Major and Minor based on patient risk and regulatory impact
- High, Medium, Low based solely on customer emotion
- Immediate, Delayed, Never based on sales impact
- Type A, Type B, Type C where types are marketing categories
Correct Answer: Critical, Major and Minor based on patient risk and regulatory impact
Q10. Under which circumstance is a product recall most likely to be initiated?
- There is a minor typographical error on a non-critical marketing brochure
- Complaints and investigation indicate a product defect that could cause serious adverse health consequences
- A single customer dislikes the product color
- There is a delay in a shipping schedule
Correct Answer: Complaints and investigation indicate a product defect that could cause serious adverse health consequences
Q11. Which documents should be included in a formal complaint investigation file?
- Complaint record, batch history and QC test data, root cause analysis, CAPA plan and verification records, communication with complainant and disposal/release decision
- Only the initial customer email
- Only marketing materials and invoices
- Internal personnel performance appraisals
Correct Answer: Complaint record, batch history and QC test data, root cause analysis, CAPA plan and verification records, communication with complainant and disposal/release decision
Q12. When laboratory testing is performed as part of a complaint investigation, the lab should:
- Test only for the original release specification and ignore complaint specifics
- Perform tests relevant to the complaint and compare results to original release and stability specifications, documenting methods and deviations
- Use any quick field test without documentation
- Return results verbally without written record
Correct Answer: Perform tests relevant to the complaint and compare results to original release and stability specifications, documenting methods and deviations
Q13. If a complaint alleges product degradation, what is an appropriate technical response?
- Recommend immediate disposal of all products without testing
- Initiate stability testing (accelerated and real-time as appropriate), review storage and distribution conditions, and compare to stability data
- Assume customer mishandling without investigation
- Blame packaging vendors without data
Correct Answer: Initiate stability testing (accelerated and real-time as appropriate), review storage and distribution conditions, and compare to stability data
Q14. What are appropriate criteria to authorize complaint closure?
- Root cause identified, CAPA implemented and effectiveness verified, documentation completed and communicant informed where necessary
- Investigation started but never completed
- CAPA planned but implementation deferred indefinitely
- Complaint closed based solely on time elapsed
Correct Answer: Root cause identified, CAPA implemented and effectiveness verified, documentation completed and communicant informed where necessary
Q15. When a complaint investigation reveals a death or serious injury potentially linked to the product, the quality unit must:
- Conceal findings to avoid reporting
- Immediately escalate to pharmacovigilance/medical safety and regulatory affairs for timely regulatory reporting and risk mitigation
- Only inform sales to manage customer relations
- Wait for monthly management review to decide
Correct Answer: Immediately escalate to pharmacovigilance/medical safety and regulatory affairs for timely regulatory reporting and risk mitigation
Q16. How is an Out of Specification (OOS) laboratory result related to a customer complaint?
- OOS is a lab result that may support the complaint investigation if testing of complaint samples shows deviation from specifications
- OOS only refers to clinical trial outcomes
- OOS and complaints are unrelated and cannot be compared
- OOS always means the complaint was fraudulent
Correct Answer: OOS is a lab result that may support the complaint investigation if testing of complaint samples shows deviation from specifications
Q17. What is the primary role of Quality Control (QC) during complaint investigations?
- Provide independent testing, data interpretation, and technical support to confirm or refute product nonconformity
- Authorize product release without testing
- Only prepare marketing responses
- Approve CAPA without evidence
Correct Answer: Provide independent testing, data interpretation, and technical support to confirm or refute product nonconformity
Q18. How should returned or allegedly defective goods be handled pending completion of investigation?
- Quarantine and tag as retained evidence; do not reintroduce into inventory without disposition
- Immediately repackage and resell
- Discard without documentation
- Use for internal training exercises without notation
Correct Answer: Quarantine and tag as retained evidence; do not reintroduce into inventory without disposition
Q19. What constitutes an effective verification of CAPA implementation for complaints?
- Documented evidence that corrective and preventive actions were implemented and measured through metrics or follow-up testing demonstrating reduction or elimination of the issue
- Stating CAPA is effective without data
- Closing CAPA based on completion date only
- Archiving CAPA records without verification
Correct Answer: Documented evidence that corrective and preventive actions were implemented and measured through metrics or follow-up testing demonstrating reduction or elimination of the issue
Q20. Which metrics are most useful to monitor the performance of a complaint handling system?
- Number of complaints per million doses, percentage of repeat complaints, average time to closure, CAPA effectiveness rate and trend of safety-significant complaints
- Only the dollar value of returned goods
- Number of marketing calls per month
- Employee headcount in the sales department
Correct Answer: Number of complaints per million doses, percentage of repeat complaints, average time to closure, CAPA effectiveness rate and trend of safety-significant complaints

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

